Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy Candidate – Genetic Engineering & Biotechnology News
|
Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy Candidate
Genetic Engineering & Biotechnology News Chiesi Group has ended its four-year-old collaboration with uniQure to co-develop and license a gene therapy for hemophilia B and has returned its development and commercialization rights to the gene therapy candidate in Europe and other areas, uniQure … |
